samedan logo
 
 
spacer
home > pmps > spring 2003 > maximising the benefits of brand security - new developments for smart protection
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Maximising the Benefits of Brand Security - New Developments for Smart Protection

Much has been said about the escalating problem and staggering numbers related to counterfeiting in the pharmaceutical industry, to the point where no large manufacturer can avoid taking a pro-active approach and initiating a product security programme. In order for a programme to be effective however, it should include some form of product marking technology, whether applied to the primary packaging, secondary packaging, labels or to all of the above.

When considering such technologies, a cost/benefit analysis will typically include an evaluation of the overall technology attributes, its applicability to specific challenges and the environment in which it is implemented. Some of the issues that need to be addressed are: the type of problem (counterfeiting, repackaging, diverting); mapping of geographical areas and distribution channels involved; suspected origins of fake drugs; existing levels of control over the supply chain; the type and amount of information that requires validation; and nature of inspection (in the field versus back office).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dana Kaplan, Vice President of Marketing and Business Development at Inksure Inc

Dana Kaplan is Vice President of Marketing & Business Development at InkSure Inc. Ms Kaplan has extensive experience in international marketing - prior to joining InkSure in 2000, she engaged in commercial and marketing management for companies operating within the consumer goods industry.

Her technical background includes experience as an R&D Chemist at Avco Chem Ltd (pigments and dyestuffs). Ms Kaplan holds a B.Tech in Textile Chemistry Engineering and an MSc in International Marketing.

spacer
Dana Kaplan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform

 Dundee, UK, 14th December 2021 – Today, Ubiquigent Limited (Ubiquigent) celebrates the 10th anniversary of its DUBprofiler™ compound profiling platform, together with KSQ Therapeutics joining its expanding customer base.
More info >>

White Papers

Clinical Trial Disclosure Management: Build vs. Buy

TrialScope

Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement